GlaxoSmithKline presented this week at the 6th Multilateral Initiative on Malaria PAN African Conference in Durban promising data from an ongoing Phase III trial on the malaria vaccine candidate RTS,S.
Dr Jeffrey Dvorin recently received a prestigious NIH Director's New Innovator Award for his project that aims at generating a list of essential genes in Plasmodium falciparum.
Trends in Parasitology, Volume 29, Issue 6, June 2013, Pages 286-294 Florian Noulin, Céline Borlon, Jan Van Den Abbeele, Umberto D’Alessandro, Annette Erhart
No comments:
Post a Comment